Pacira Pharmaceuticals Inc (PCRX) Insider Trading
- $1,702,348.30
- $212,284,233.46
- Sept. 13, 2024
- Andreas Wicki
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 13, 2024 | COO | 500 | $12.86 | Sell | $6,430.00 | |
Aug. 16, 2024 | Director | 1,512 | $13.25 | Buy | $20,034.00 | |
Aug. 12, 2024 | Director | 1,400 | $11.58 | Buy | $16,212.00 | |
Aug. 12, 2024 | CEO | 8,264 | $12.10 | Buy | $99,994.40 | |
Aug. 2, 2024 | Insider | 945 | $20.05 | Sell | $18,947.25 | |
July 2, 2024 | Insider | 2,836 | $28.25 | Sell | $80,117.00 | |
June 13, 2024 | Insider | 7,452 | $28.38 | Sell | $211,487.76 | |
June 13, 2024 | Director | 880 | $28.38 | Sell | $24,974.40 | |
June 13, 2024 | COO | 1,000 | $28.38 | Sell | $28,380.00 | |
June 12, 2024 | SVP | 3,970 | $28.72 | Sell | $114,018.40 | |
June 11, 2024 | Insider | 5,012 | $28.57 | Sell | $143,192.84 | |
March 8, 2024 | Director | 90,000 | $30.60 | Sell | $2,754,000.00 | |
March 6, 2024 | Director | 1,066 | $29.67 | Sell | $31,628.22 | |
Aug. 2, 2023 | Insider | 509 | $34.88 | Sell | $17,753.92 | |
July 5, 2023 | SVP | 643 | $38.91 | Sell | $25,019.13 | |
June 14, 2023 | SVP | 6,366 | $38.42 | Sell | $244,581.72 | |
June 14, 2023 | Insider | 6,467 | $37.03 | Sell | $239,473.01 | |
June 8, 2023 | Director | 15,000 | $37.04 | Sell | $555,600.00 | |
June 7, 2023 | COO | 1,047 | $37.87 | Sell | $39,649.89 | |
June 6, 2023 | Insider | 1,779 | $38.99 | Sell | $69,363.21 | |
June 6, 2023 | SVP | 591 | $38.99 | Sell | $23,043.09 | |
June 6, 2023 | CEO | 5,058 | $38.99 | Sell | $197,211.42 | |
June 6, 2023 | CFO | 1,236 | $38.99 | Sell | $48,191.64 | |
June 5, 2023 | Director | 580 | $38.34 | Sell | $22,237.20 | |
June 5, 2023 | COO | 1,000 | $38.74 | Sell | $38,740.00 | |
May 31, 2023 | COO | 2,500 | $39.08 | Sell | $97,700.00 | |
May 11, 2023 | Director | 5,015 | $41.78 | Sell | $209,526.70 | |
Jan. 5, 2023 | Insider | 546 | $38.31 | Sell | $20,917.26 | |
Oct. 7, 2022 | Insider | 1,380 | $58.00 | Sell | $80,040.00 | |
Aug. 3, 2022 | Insider | 476 | $55.70 | Sell | $26,513.20 | |
July 11, 2022 | N/A | 533 | $56.95 | Sell | $30,354.35 | |
July 5, 2022 | Insider | 924 | $57.19 | Sell | $52,843.56 | |
June 8, 2022 | Insider | 4,937 | $59.82 | Sell | $295,331.34 | |
June 8, 2022 | CEO | 13,828 | $59.85 | Sell | $827,605.80 | |
June 6, 2022 | Insider | 17,546 | $61.39 | Sell | $1,077,148.94 | |
June 6, 2022 | SVP | 1,150 | $61.37 | Sell | $70,575.50 | |
June 6, 2022 | CEO | 11,965 | $61.37 | Sell | $734,292.05 | |
June 6, 2022 | COO | 1,106 | $61.37 | Sell | $67,875.22 | |
June 6, 2022 | CFO | 2,516 | $61.37 | Sell | $154,406.92 | |
May 9, 2022 | Director | 1,000 | $59.37 | Sell | $59,370.00 | |
April 21, 2022 | Insider | 9,824 | $73.25 | Sell | $719,608.00 | |
April 19, 2022 | Insider | 9,321 | $72.25 | Sell | $673,442.25 | |
April 6, 2022 | Insider | 22,500 | $76.42 | Sell | $1,719,450.00 | |
March 21, 2022 | Insider | 7,253 | $72.67 | Sell | $527,075.51 | |
March 10, 2022 | SVP | 9,300 | $71.22 | Sell | $662,346.00 | |
March 3, 2022 | Director | 7,000 | $71.73 | Sell | $502,110.00 | |
March 1, 2022 | Director | 1,359 | $67.75 | Sell | $92,072.25 | |
Feb. 25, 2022 | Insider | 2,050 | $67.02 | Sell | $137,391.00 | |
Feb. 16, 2022 | Insider | 10 | $65.00 | Sell | $650.00 | |
Feb. 4, 2022 | Insider | 1,000 | $65.18 | Sell | $65,180.00 |
Insiders are both buying and selling Pacira Pharmaceuticals Inc stock.
The insider traders at Pacira Pharmaceuticals Inc are: Andreas Wicki, Lauren Bullaro Riker, David M Stack, Kristen Marie Williams, David M. Stack, Paul J Hastings, James S Scibetta, Roy Winston, Max Reinhardt, Gary W Pace, Charles A Reinhart III, John P Phd Longenecker, Daryl Gaugler, Gary Patou, Mark A Kronenfeld, Charles Anthony Laranjeira, Jonathan Slonin, Taunia Markvicka, Luke Evnin, Mark Froimson, Richard Scranton, John Phd Longenecker, James B Jones, John Pratt, Fred A Middleton, Laura Brege, David Stack, Scott Braunstein, Anthony Molloy, James Scibetta, James B. Jones, Marcelo Bigal, Donald C Manning, James S. Scibetta, HASTINGS PAUL J, Dennis Mcloughlin, Kristen Williams, Dennis L Winger, Frank D Lee, and Lauren Riker
The most active insider trader at Pacira Pharmaceuticals Inc is Andreas Wicki with 38 trades.
Andreas Wicki has sold the most Pacira Pharmaceuticals Inc stock with a total value of $103,301,745.13.
Gary W Pace has bought the most Pacira Pharmaceuticals Inc stock with a total value of $714,610.00.
The most recent insider trade for Pacira Pharmaceuticals Inc was on Sept. 13, 2024.
The single biggest insider buy for Pacira Pharmaceuticals Inc was from James S Scibetta with a total value of $306,850.00 on Sept. 11, 2015.
The single biggest insider sell for Pacira Pharmaceuticals Inc was from Andreas Wicki with a total value of $15,187,500.00 on Aug. 11, 2014.